In the present study, we 
The majority (50-70%) of human immunodeficiency virus type 1 (HIV-1)-infected individuals experience a clinical syndrome of variable severity associated with primary infection (1) (2) (3) (4) (5) . Due to the lack of specificity of the clinical symptoms and to the fact that hospitalization is required in only a minority (10-15%) of individuals with a severe clinical syndrome, primary HIV infection generally goes unnoticed (1) (2) (3) (4) (5) . Recently, however, substantial progress has been made in the delineation of the virologic and immunologic events associated with primary infection. Virologic parameters including plasma viremia, p24 antigenemia, and HIV RNA expression in peripheral blood mononuclear cells (PBMC) are extremely high during this stage of infection (3) (4) (5) . The high levels of viremia coincide with the clinical syndrome, and both down-regulation of viremia and disappearance of symptoms generally occur within 4-8 weeks; it is thought that the decrease of virologic parameters and the resolution of symptoms are the result of an HIV-specific immune response (3) (4) (5) . Both vigorous humoral and cell-mediated immune responses are associated with primary infection (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . With regard to the latter, oligoclonal expansions of CD8+, virus-specific, cytotoxic T lymphocytes represent a major component of the primary HIV-specific cell-mediated immune response (8) ; a similar phenomenon has been observed in the experimental simian immunodeficiency
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virus model of acute infection (12) . It has been proposed that virus-specific cytotoxic CD8+ T lymphocytes represent the primary mechanism responsible for the dramatic downregulation of virologic parameters by the elimination of a large number of virus-expressing cells (6-8, 10, 11) . With regard to the humoral immune response, the observation that neutralizing antibodies are detected when transition from the acute to the chronic phase of infection has already occurred suggests that this response may have little effect on the initial spreading of virus (6, 9) . However, HIV-binding antibodies appear before neutralizing antibodies, and it is conceivable that this former humoral response may contribute to the removal of virus particles from the circulation and thus to the downregulation of viremia by promoting the formation of immune complexes (virus plus immunoglobulin plus complement) that may be cleared through and trapped in the reticuloendothelial system (10, 11) .
Cytokines mediate a number of important immunoregulatory functions and play a critical role in the modulation of the immune response to different pathogens (13) . The (21) (22) (23) .
Quantitation of Cytokine Expression. Cytokine expression was determined by a semiquantitative reverse transcriptase-PCR assay as described (17) . The triphosphate (Amersharm) corresponding to 500,000 to 1,000,000 cpm/,ll was also added. With regard to magnesium concentration, it was determined that optimal amplification occurred in the presence of 1.5 mM MgCl2 for IL-4, IL-6, IL-10, and TNF-a; in the presence of 2 mM MgCl2 for IL-2; and in the presence of 2.5 mM MgCl2 for IFN-y. After determination of the number of PCR cycles required to ensure linearity of amplification, 25 cycles were chosen for TNF-a, 28 cycles for IFN--y and IL-10, and 31 cycles for IL-2, IL-4, and IL-6. Products of amplification were analyzed by electrophoresis in 5% 29:1 polyacrylamide gels and visualized by autoradiography. The intensity of the signal for each cytokine was measured by a Phosphorlmager (Molecular Dynamics). A simple regression curve was fitted for the two-fold dilution of the standard cDNA, and the equation obtained was used to determine the relative amounts of target sequence in the patient samples. Results are expressed as fold increase over the positive control (i.e., the last dilution of the standard cDNA in which amplified products could be detected). We have previously shown that constitutive expression of the cytokines analyzed in the present study was generally not detected in PBMC of HIV-negative seronegative donors (17) .
Analysis of T-Cell Subsets. T-cell subsets, as determined by the variable (V) region of the ,3 chain of the T-cell receptor (Vj3 repertoire) in unfractionated PBMC collected at different times from the onset of symptoms, were analyzed by a semiquantitative PCR as described (8, 27, 28 Analysis of the patterns of cytokine expression during primary infection showed substantial differences in the kinetics within the panel of cytokines studied. However, certain cytokines had similar patterns of expression; for these reasons, the data regarding those cytokines with similar kinetics will be examined and discussed together. Expression of IL-2 and IL-4 was generally not detected (Fig. 1A) or barely detected (Fig.  1B) 30 (Fig. 1B) were similar to those found in patient 27 (data not shown). A substantial increase over time of the levels of IL-2 (Fig. 1C) , and to a lesser extent of those of IL-4 (Fig. 1C) (Fig. 1A) , and to a lesser extent of IL-4 (Fig. 1A) , were observed in lymph node at a time (day 28) when expression of both cytokines was not detected in peripheral blood (Fig. 1A) . In addition, the levels of expression of IL-6, IL-10, IFN-7, and TNF-a were significantly higher (3-fold for each cytokine) in lymph node compared to peripheral blood (data not shown). Therefore, these results indicate that the lack of detection of expression of IL-2 and IL-4 in peripheral blood during primary infection does not necessarily mean that a similar situation exists in other lymphoid compartments.
Expression of IL-6 was not detected in peripheral blood in the majority (6) of patients with primary infection (Fig. 2 ).
However, in three patients (patients 2, 15, and 17) expression of IL-6 was detected in PBMC samples collected late during primary infection (Fig. 2) at a time when down-regulation of viremia had already occurred.
Kinetics of expression of IL-10 and TNF-a were almost identical. Expression of both cytokines was consistently observed in peripheral blood in all nine patients studied (Fig. 3) . In four (patients 2, 15, 17, and 27) of nine patients, expression of IL-10 and TNF-a progressively increased over time (Fig.  3A) , and levels of both cytokines peaked when the transition from the acute to the chronic phase of infection had already occurred. No major changes in the levels of expression of these cytokines between early and late time points were observed in patients 3, 4, and 6 (Fig. 3B) . A transient increase in the levels of IL-10 and TNF-a was observed in patient 30 during the course of primary infection (Fig. 3C) ; patient 1 was the only individual in whom a peak of both cytokines was detected in the PBMC samples collected at the early time points (Fig. 3D ).
Similar to IL-10 and TNF-a, expression of IFN-y was detected in all patients included in this study. Two dominant patterns of IFN-y expression were observed. Levels of IFN-y expression were low and stable throughout primary infection, including the transition from the acute to the chronic phase of infection; this pattern was observed in four patients (patients 3, 4, 6, and 27) (Fig. 4A) . A peak in the expression of IFN-y was observed in the other five patients (patients 1, 2, 15, 17, and 30) (Fig. 4B) Proc. Natl. Acad. Sci. USA 93 (1996) ,Its~Can~ to day 40) (Fig. 4B) (Fig. 4C) . It is clear that in these patients the kinetics of the expanded Vj3s overlapped with those of IFN-7y expression (Fig. 4B) 
